Virus-like particles-universal molecular toolboxes (Q37033555)

17 August 2017

2 references

22 August 2022

Virus-like particles-universal molecular toolboxes (English)

1 reference

17 August 2017

0 references

Christine Ludwig

1

1 reference

PubMed ID

18083549

17 August 2017

Ralf Wagner

series ordinal

2

1 reference

17 August 2017

1 December 2007

2 references

Current Opinion in Biotechnology

17 August 2017

22 August 2022

2 references

17 August 2017

22 August 2022

18

1 reference

17 August 2017

6

1 reference

17 August 2017

537-545

1 reference

Yeast-derived human immunodeficiency virus type 1 p55(gag) virus-like particles activate dendritic cells (DCs) and induce perforin expression in Gag-specific CD8(+) T cells by cross-presentation of DCs

17 August 2017

1 reference

12 December 2020

Selective elimination of HIV-1-infected cells by Env-directed, HIV-1-based virus-like particles.

1 reference

12 December 2020

Human hepatitis B vaccine from recombinant yeast

1 reference

12 December 2020

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

1 reference

12 December 2020

Ted Slavin's blood and the development of HBV vaccine.

1 reference

12 December 2020

Virus-like particles production in green plants

1 reference

12 December 2020

Icosahedral virus particles as addressable nanoscale building blocks

1 reference

12 December 2020

Virus-like particles as vaccines and vessels for the delivery of small molecules

1 reference

12 December 2020

Membrane embedded HIV-1 envelope on the surface of a virus-like particle elicits broader immune responses than soluble envelopes

1 reference

12 December 2020

Baculovirus-derived human immunodeficiency virus type 1 virus-like particles activate dendritic cells and induce ex vivo T-cell responses.

1 reference

12 December 2020

Particles associated with Australia antigen in the sera of patients with leukaemia, Down's Syndrome and hepatitis

1 reference

12 December 2020

Priming of strong, broad, and long-lived HIV type 1 p55gag-specific CD8+ cytotoxic T cells after administration of a virus-like particle vaccine in rhesus macaques.

1 reference

12 December 2020

Cellular delivery of siRNA mediated by fusion-active virosomes.

1 reference

12 December 2020

Virus-enabled synthesis and assembly of nanowires for lithium ion battery electrodes

1 reference

12 December 2020

Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases

1 reference

12 December 2020

Ebola virus-like particles produced in insect cells exhibit dendritic cell stimulating activity and induce neutralizing antibodies

1 reference

12 December 2020

Cellular gene transfer mediated by influenza virosomes with encapsulated plasmid DNA.

1 reference

12 December 2020

Rational modifications of HIV-1 envelope glycoproteins for immunogen design

1 reference

12 December 2020

Virosome-mediated delivery of tumor antigen to plasmacytoid dendritic cells

1 reference

12 December 2020

Virus-like particles as HIV-1 vaccines

1 reference

12 December 2020

Induction of systemic and mucosal cross-clade neutralizing antibodies in BALB/c mice immunized with human immunodeficiency virus type 1 clade A virus-like particles administered by different routes of inoculation

1 reference

12 December 2020

Targeting her-2/neu with antirat Neu virosomes for cancer therapy

1 reference

12 December 2020

Lentiviral vectors pseudotyped with baculovirus gp64 efficiently transduce mouse cells in vivo and show tropism restriction against hematopoietic cell types in vitro

1 reference

12 December 2020

Comparative analysis using a mouse model of the immunogenicity of artificial VLP and attenuated Salmonella strain carrying a DNA-vaccine encoding HIV-1 polyepitope CTL-immunogen.

1 reference

12 December 2020

Optimized Malaria-antigens delivered by immunostimulating reconstituted influenza virosomes

1 reference

12 December 2020

Protection against EHV-1 challenge infection in the murine model after vaccination with various formulations of recombinant glycoprotein gp14 (gB).

1 reference

12 December 2020

Liposomes and virosomes as delivery systems for antigens, nucleic acids and drugs

1 reference

12 December 2020

Incorporation of glycosylphosphatidylinositol-anchored granulocyte- macrophage colony-stimulating factor or CD40 ligand enhances immunogenicity of chimeric simian immunodeficiency virus-like particles

1 reference

12 December 2020

Baculovirus induces an innate immune response and confers protection from lethal influenza virus infection in mice

1 reference

12 December 2020

Intranasal immunization with mumps virus DNA vaccine delivered by influenza virosomes elicits mucosal and systemic immunity.

1 reference

12 December 2020

Production of human papillomavirus type 16 L1 virus-like particles by recombinant Lactobacillus casei cells

1 reference

12 December 2020

Immune responses against severe acute respiratory syndrome coronavirus induced by virus-like particles in mice

1 reference

12 December 2020

Studies on processing, particle formation, and immunogenicity of the HIV-1 gag gene product: a possible component of a HIV vaccine.

1 reference

12 December 2020

Immunogenicity and adverse effects of inactivated virosome versus alum-adsorbed hepatitis A vaccine: a randomized controlled trial

1 reference

12 December 2020

Virus-based toolkit for the directed synthesis of magnetic and semiconducting nanowires.

1 reference

12 December 2020

Enhanced presentation of major histocompatibility complex class I-restricted human immunodeficiency virus type 1 (HIV-1) Gag-specific epitopes after DNA immunization with vectors coding for vesicular stomatitis virus glycoprotein-pseudotyped HIV-1 G

1 reference

12 December 2020

Virus-like particles: passport to immune recognition

1 reference

12 December 2020

Virus-like particle expression and assembly in plants: hepatitis B and Norwalk viruses

1 reference

12 December 2020

Generation and immunogenicity of novel HIV/AIDS vaccine candidates targeting HIV-1 Env/Gag-Pol-Nef antigens of clade C

1 reference

12 December 2020

Assembly and release of HIV-1 precursor Pr55gag virus-like particles from recombinant baculovirus-infected insect cells

1 reference

12 December 2020

Induction of a MHC class I-restricted, CD8 positive cytolytic T-cell response by chimeric HIV-1 virus-like particles in vivo: implications on HIV vaccine development.

1 reference

12 December 2020

Versatile RHDV virus-like particles: incorporation of antigens by genetic modification and chemical conjugation

1 reference

12 December 2020

Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections

1 reference

12 December 2020

Influenza virosomes as an efficient system for adjuvanted vaccine delivery.

1 reference

12 December 2020

Virus-like particles: designing an effective AIDS vaccine

1 reference

12 December 2020

Clinical applications of virosomes in cancer immunotherapy

1 reference

12 December 2020

Self-Assembly and Cross-Linking of Bionanoparticles at Liquid-Liquid Interfaces

1 reference

12 December 2020

Recombinant HIV-1 Pr55gag virus-like particles: potent stimulators of innate and acquired immune responses

1 reference

12 December 2020

Structure-activity-based design of a synthetic malaria peptide eliciting sporozoite inhibitory antibodies in a virosomal formulation

1 reference

12 December 2020

Immune-reconstituted influenza virosome containing CD40L gene enhances the immunological and protective activity of a carcinoembryonic antigen anticancer vaccine

1 reference

12 December 2020

Immunogenicity and efficacy of immunodeficiency virus-like particles pseudotyped with the G protein of vesicular stomatitis virus

1 reference

12 December 2020

Viral vectors for the expression of proteins in plants

1 reference

12 December 2020

Human immunodeficiency virus-like particles activate multiple types of immune cells.

1 reference

12 December 2020

Enhancement of the immunogenicity of synthetic carbohydrates by conjugation to virosomes: a leishmaniasis vaccine candidate

1 reference

12 December 2020

Applications of influenza virosomes as a delivery system.

1 reference

12 December 2020

DNA vaccines encoding retrovirus-based virus-like particles induce efficient immune responses without adjuvant.

1 reference

12 December 2020

Changing viral tropism using immunoliposomes alters the stability of gene expression: implications for viral vector design.

1 reference

12 December 2020

Involvement of the Toll-like receptor 9 signaling pathway in the induction of innate immunity by baculovirus

1 reference

12 December 2020

Insect baculoviruses strongly potentiate adaptive immune responses by inducing type I IFN

1 reference

12 December 2020

10.1016/J.COPBIO.2007.10.013

Identifiers

DOI

1 reference

17 August 2017

0 references

1 reference

PubMed ID

18083549